Masimo Corporation (NASDAQ:MASI) is set to announce second quarter earning results on Tuesday 28th July 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, MASI to report 2Q20 income of $ 0.81 per share from revenue of $ 289.73 million.
For the full year, analysts anticipate top line of $ 1064.22 million, while looking forward to income of $ 3.35 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 1,035.00 million ~ $ 1,035.00 million, where as bottomline are predicted in a range of $ 3.56 ~ $ 3.56 per share
Click Here For More Historical Outlooks Of Masimo Corporation
Previous Quarter Performance
Masimo Corporation came out with income for the first quarter of $ 0.97 per share, from the revenue of $ 269.62 million. The quarterly earnings swell 22.78 percent while revenues extended 20.53 percent compared with the same quarter last year.
Street analysts expected Masimo Corporation to report income of $ 0.90 per share on revenue of $ 257.77 million for the first quarter. The bottom line results beat street analysts by $ 0.07 or 7.78 percent, at the same time, top line results outshined analysts by $ 11.85 million or 4.60 percent.
Historical Earnings Performance
wpDataChart with provided ID not found! wpDataTable with provided ID not found!Click Here For More Historical Earnings Of Masimo Corporation
Stock Performance
According to the previous trading day, closing price of MASI was $ 235.71, representing a 69.14 % increase from the 52 week low of $ 139.36 and a 8.64 % decrease over the 52 week high of $ 258.00.
The company has a market capital of $ 12.76 billion and is part of the Healthcare sector and Medical Instruments & Supplies industry.
[stock_market_widget type=”chart” template=”basic” color=”orange” assets=”MASI” range=”1y” interval=”1mo” axes=”true” cursor=”true” api=”yf” style=”height: 400px;”]
Conference Call
Masimo Corporation will be hosting a conference call at 4:30 PM eastern time on 28th July 2020, to discuss its 2Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.masimo.com
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index.